Literature DB >> 10800759

Idiopathic hypercalciuria: O2(-)NO relationship and altered bone metabolism.

L Calò1, S Giannini, P Bonvicini, M Nobile, S Cantaro, M Plebani, A Semplicini, A D'Angelo, G Crepaldi.   

Abstract

The pathogenesis of idiopathic hypercalciuria (IH) has not been elucidated yet, but a correlation between IH and altered bone metabolism has been proposed. Since nitric oxide (NO) regulates osteoclasts' bone resorption, a possible role for NO can be suggested. In this study we evaluated iNOS gene expression by reverse transcription of mRNA from monocytes, followed by polymerase chain reaction in patients with IH subdivided into fasting (FH) and absorptive (AH) hypercalciuria. Since superoxide (O2-), which metabolizes NO, is overproduced by osteoclasts during bone resorption, peroxynitrite plasma level was evaluated as index of O2-. Vertebral BMD in IH as a whole group was lower vs controls (C) (Z score=-1.78+/-0.2 vs 0.51+/-0.25, p<0.001), but only FH patients showed a reduced bone density (2.13+/-0.18 vs 0.51+/-0.25, p<0.0001). PTH and calcitriol were not different. FH showed an increase in b-ALP vs AH and C (41.1+/-2.6 vs 30.1+/-3.9 vs 26.6+/-3.6 U/l p<0.02), and higher uHP, either on NCD (17.7+/-1.6 vs 11.4+/-1.3 mg/g uCr, p<0.04) or after LCD (26.7+/-2.5 vs 16.7+/-1.9, p<0.01). Cells from FH patients, but not from both AH patients and C, expressed iNOS. Peroxynitrite plasma level was elevated in FH (0.30+/-0.07) pmol/l while not detectable in AH and C. This study confirms an altered bone metabolism only in FH which shows an abnormal NO system. The increased iNOS gene expression in FH, in fact, points toward an altered NO system's activity downstream the generation of NO. A possible interaction of NO with O2-, which breaks down NO, and the role of this interaction in the pathophysiology of IH is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800759     DOI: 10.1007/bf03343683

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Vertebral mineral content in diet-dependent and diet-independent hypercalciuria.

Authors:  L Borghi; T Meschi; A Guerra; L Maninetti; M Pedrazzoni; A Marcato; P Vescovi; A Novarini
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

2.  ecNOS overexpression in CsA-treated renal transplant patients: implications for CsA-induced hypertension.

Authors:  L Calò; P A Davis; P Rigotti; M Milani; S Cantaro; F Marchini; A D'Angelo; A Antonello
Journal:  Transplant Proc       Date:  1998-08       Impact factor: 1.066

3.  Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria.

Authors:  J R Weisinger; E Alonzo; E Bellorín-Font; A M Blasini; M A Rodriguez; V Paz-Martínez; R Martinis
Journal:  Kidney Int       Date:  1996-01       Impact factor: 10.612

4.  Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma.

Authors:  S B Rosalki; A Y Foo
Journal:  Clin Chem       Date:  1984-07       Impact factor: 8.327

5.  Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.

Authors:  R J van't Hof; S H Ralston
Journal:  J Bone Miner Res       Date:  1997-11       Impact factor: 6.741

6.  Bone density and skeletal metabolism are altered in idiopathic hypercalciuria.

Authors:  S Giannini; M Nobile; L Sartori; L Calò; A Tasca; L Dalle Carbonare; M Ciuffreda; A D'Angelo; F Pagano; G Crepaldi
Journal:  Clin Nephrol       Date:  1998-08       Impact factor: 0.975

7.  Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

Authors:  I MacIntyre; M Zaidi; A S Alam; H K Datta; B S Moonga; P S Lidbury; M Hecker; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins.

Authors:  S H Ralston; P S Grabowski
Journal:  Bone       Date:  1996-07       Impact factor: 4.398

9.  Secondary hyperparathyroidism in idiopathic renal hypercalciuria: fact or theory?

Authors:  P Burckhardt; P Jaeger
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

10.  Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.

Authors:  C Y Pak; F Britton; R Peterson; D Ward; C Northcutt; N A Breslau; J McGuire; K Sakhaee; S Bush; M Nicar; D A Norman; P Peters
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.